← Leaderboards
John B Rose
University Of Alabama At Birmingham
$848,070
Attributed
$848,070
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $212.8K · FY2019–23$250K$187.5K$125K$62.5K$0
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$848,070 · 1
By mechanism
K08$848,070 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Alabama At Birmingham
Same institution · by research overlap
- James N. Odom$7,817,083
- Kirby I Bland$6,784,098
- Ralph R Weichselbaum$16,065,057
- Lisa Zubkoff$3,314,016
- Sadis Matalon$21,362,558
Others in their field
Other Emerging Leaders on “Histone Deacetylase Inhibitor”
- Nashaat Turkman · State University New York Stony Brook$2,977,995
- Shujie Yang · University Of Iowa$2,440,269
- Yuan Liu · University Of Pittsburgh At Pittsburgh$2,358,330
- Guochun Jiang · Univ Of North Carolina Chapel Hill$2,351,248
- Peeyush Kumar Thankamani Pandit · University Of Texas Hlth Sci Ctr Houston$2,261,504
- Libusha Kelly · Albert Einstein College Of Medicine$2,197,616
Research focus
Histone Deacetylase InhibitorMentorsEnvironmentGastrointestinal Tract StructureInvestigationMalignant NeoplasmsAnimal ModelDrug TestingEugeniaGastroenteropancreatic Neuroendocrine TumorHormonesHormone SecretionClinical ApplicationMalignant Neoplasm Of Gastrointestinal TractBiomedical EngineeringCytotoxicBioreactorsDrug TargetingDisabling SymptomBasic ScienceDrug EfficacyExcisionChemistryMid-Career Faculty
Grant awards (6)
Targeted Treatment of Metastatic Gastroenteropancreatic Neuroendocrine Tumors$158,814
K08 · FY2023 · CA · contact PI
Targeted Treatment of Metastatic Gastroenteropancreatic Neuroendocrine Tumors$158,814
K08 · FY2022 · CA · contact PI
Targeted Treatment of Metastatic Gastroenteropancreatic Neuroendocrine Tumors$158,814
K08 · FY2021 · CA · contact PI
Targeted Treatment of Metastatic Gastroenteropancreatic Neuroendocrine Tumors$158,814
K08 · FY2020 · CA · contact PI
Targeted Treatment of Metastatic Gastroenteropancreatic Neuroendocrine Tumors$54,000
K08 · FY2020 · CA · contact PI
Targeted Treatment of Metastatic Gastroenteropancreatic Neuroendocrine Tumors$158,814
K08 · FY2019 · CA · contact PI